Some visit links earn us a commission.

Zepbound vs Ozempic cost: $299 vs $349 a month and up

Prices checked November 16, 2026

No insurance needed. Two programs to check.

Zepbound and Ozempic are different medicines with different approvals. Zepbound is tirzepatide from Eli Lilly, approved for weight loss and sleep apnea. Ozempic is semaglutide from Novo Nordisk, approved for type 2 diabetes. Paying cash, Zepbound starts at $299 a month at 2.5 mg and Ozempic is $349 to $499 a month by dose.

Zepbound vs Ozempic, side by side

Zepbound and Ozempic compared on medicine, approval, cash price, savings card, Medicare and doses
ZepboundOzempic
Medicine
TirzepatideSemaglutide
Sold for cash by
LillyDirect (Eli Lilly)NovoCare (Novo Nordisk)
Approved for
Weight loss. Also obstructive sleep apnea in adults with obesityType 2 diabetes. Also lowers heart and kidney risk in people with type 2 diabetes
Cash price
$299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up$349 to $499 a month by dose
Savings card, with commercial insurance
As low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026As low as $25/mo (max $100/mo off)
Medicare GLP-1 Bridge
$50 a month, Zepbound KwikPen onlyNot included
Doses
5 mg, 10 mg or 15 mg. For sleep apnea, 10 mg or 15 mg. Highest dose 15 mg weekly0.5 mg, 1 mg or 2 mg, based on glycemic control. Highest dose 2 mg weekly

Cash prices are the makers' own, checked November 16. You need a prescription for either.

What each costs without insurance

LillyDirect prices Zepbound by dose: $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up. The $449 price needs a refill within 45 days. NovoCare sells Ozempic at $349 to $499 a month by dose.

So Zepbound costs less at the starting dose and more from 5 mg. Every Zepbound dose and form: Zepbound cost. Ozempic: Ozempic cost.

Why the label matters more than the price

A plan pays for Ozempic when you have type 2 diabetes. It pays for Zepbound only where it covers weight loss or sleep apnea, usually after prior approval. Without diabetes, an Ozempic prescription for weight loss is off-label and plans rarely pay for it.

With commercial insurance, the savings cards read: Zepbound, as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300) until December 31, 2026; Ozempic, as low as $25/mo (max $100/mo off).

Medicare covers Ozempic for diabetes and Zepbound for sleep apnea. Its GLP-1 Bridge charges $50 a month for the Zepbound KwikPen to people who qualify, from July 1, 2026 to December 31, 2027. The Zepbound vials do not qualify.

Tirzepatide against semaglutide

SURMOUNT-5 compared the two medicines for weight loss in adults with obesity and no diabetes, using Wegovy's semaglutide doses rather than Ozempic's. Over 72 weeks, tirzepatide took off 20.2 percent of body weight on average against 13.7 percent.

Ozempic's own trials measured blood sugar in type 2 diabetes. Which medicine suits you is a question for your prescriber.

Questions people ask

Is Zepbound cheaper than Ozempic?
At the 2.5 mg starting dose, yes: $299 a month at LillyDirect against $349 for Ozempic at NovoCare. From 5 mg, Zepbound is $399 and up.
Are Zepbound and Ozempic the same drug?
No. Zepbound is tirzepatide from Eli Lilly and Ozempic is semaglutide from Novo Nordisk. Zepbound is approved for weight loss and Ozempic for type 2 diabetes.
Which causes more weight loss, Zepbound or Ozempic?
In SURMOUNT-5, tirzepatide took off 20.2 percent of body weight on average against 13.7 percent for semaglutide at Wegovy's doses, over 72 weeks.
Does insurance cover Zepbound or Ozempic?
Plans cover Ozempic for type 2 diabetes. Zepbound is covered where a plan includes weight loss or sleep apnea, usually after prior approval.

Compare other GLP-1 medications

Sources

Evidence checked November 9, 2026

Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.

3 documents

  1. What Zepbound is approved for and its dosesFDA prescribing information for Zepbound (DailyMed, revised August 2026)
  2. What Ozempic is approved for and its dosesFDA prescribing information for Ozempic injection (DailyMed, revised June 2026)
  3. SURMOUNT-5: tirzepatide against semaglutide for weight loss, 20.2 percent against 13.7 percent at 72 weeksSURMOUNT-5, Aronne et al., N Engl J Med 2025;393:26-36

Prices from NovoCare and LillyDirect and the makers' savings card pages, checked November 16. How we check prices.